29 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
the YTD total for new prescribers to 89
Continued engagement with broad group of endocrinologists during the quarter through in person calls and presence
6-K
EX-99.1
AMYT
Amryt Pharma Plc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
with their instructions, at the AGM.
AGM - Listen-Live Facility: To support engagement with our Shareholders, a listen-live telephone facility
6-K
EX-99.2
AMYT
Amryt Pharma Plc
13 Sep 21
Current report (foreign)
8:48am
OF TREATMENT IN SEVERE EB* 49 Preparing for Launch Dedicated expert medical affairs team in field Early payer engagement Dedicated dermatology commercial
424B3
ek79p0wu
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
cfzdx5s
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
424B3
wj4wtytcwv3z uul
28 Jun 21
Prospectus supplement
9:18am
424B3
zhiwyjy
28 Jun 21
Prospectus supplement
9:17am
6-K
EX-99.1
ggbqxhl g8d3npb58
28 Jun 21
Current report (foreign)
9:16am
F-4
cuytc2u 9ng
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
5vcnh 4udz5ek7ly6p4
2 Jun 21
Prospectus supplement
10:10am
424B3
3yftih50 urwgav
2 Jun 21
Prospectus supplement
10:09am
20-F
y8uksin 9209
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.3
9xxgnq6hdae6qlr1d
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
l3m8iok
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-10.1
4xr7xo5
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
mf3p8tw2
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
1cggeecxm08o7myg5
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
F-1/A
EX-10.13
yzn4v61sxyl
6 Jul 20
Registration statement (foreign) (amended)
5:28pm